| Product Code: ETC10706962 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Japan saw a notable decrease in ophthalmic drugs and devices import shipments, with the USA, Germany, Switzerland, Ireland, and Sweden emerging as the top exporting countries. The market exhibited very low concentration, indicating a diverse range of sources for these products. The compound annual growth rate (CAGR) for 2020-2024 was -3.59%, with a slight improvement in the growth rate from 2023 to 2024 at -1.52%. This data suggests a challenging market environment, but also opportunities for innovation and expansion in the ophthalmic sector in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Ophthalmic Drugs Devices Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Ophthalmic Drugs Devices Market - Industry Life Cycle |
3.4 Japan Ophthalmic Drugs Devices Market - Porter's Five Forces |
3.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Japan Ophthalmic Drugs Devices Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Japan Ophthalmic Drugs Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.8 Japan Ophthalmic Drugs Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Japan Ophthalmic Drugs Devices Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
4 Japan Ophthalmic Drugs Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and disorders in Japan |
4.2.2 Technological advancements in ophthalmic drugs and devices |
4.2.3 Growing elderly population in Japan requiring eye care services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of ophthalmic drugs and devices in Japan |
4.3.2 High cost associated with advanced ophthalmic drugs and devices |
4.3.3 Limited awareness about eye health and treatment options among the general population in Japan |
5 Japan Ophthalmic Drugs Devices Market Trends |
6 Japan Ophthalmic Drugs Devices Market, By Types |
6.1 Japan Ophthalmic Drugs Devices Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.1.4 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Oral, 2021 - 2031F |
6.1.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Ointments, 2021 - 2031F |
6.1.6 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Eye Drops, 2021 - 2031F |
6.2 Japan Ophthalmic Drugs Devices Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Topical, 2021 - 2031F |
6.2.3 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Implantable, 2021 - 2031F |
6.2.4 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
6.2.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Ophthalmic Patches, 2021 - 2031F |
6.3 Japan Ophthalmic Drugs Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Devices, 2021 - 2031F |
6.3.3 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Surgical Instruments, 2021 - 2031F |
6.3.4 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Vision Correction, 2021 - 2031F |
6.3.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Diagnostic Imaging, 2021 - 2031F |
6.4 Japan Ophthalmic Drugs Devices Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Glaucoma, 2021 - 2031F |
6.4.3 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Cataract, 2021 - 2031F |
6.4.4 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Dry Eye, 2021 - 2031F |
6.4.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Retinal Disorders, 2021 - 2031F |
6.5 Japan Ophthalmic Drugs Devices Market, By Formulation |
6.5.1 Overview and Analysis |
6.5.2 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.5.3 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Gel, 2021 - 2031F |
6.5.4 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Cream, 2021 - 2031F |
6.5.5 Japan Ophthalmic Drugs Devices Market Revenues & Volume, By Powder, 2021 - 2031F |
7 Japan Ophthalmic Drugs Devices Market Import-Export Trade Statistics |
7.1 Japan Ophthalmic Drugs Devices Market Export to Major Countries |
7.2 Japan Ophthalmic Drugs Devices Market Imports from Major Countries |
8 Japan Ophthalmic Drugs Devices Market Key Performance Indicators |
8.1 Number of approved ophthalmic drugs and devices in Japan |
8.2 Rate of adoption of new technologies in the ophthalmic sector |
8.3 Number of ophthalmic procedures performed in Japan |
8.4 Patient satisfaction levels with ophthalmic treatment services |
8.5 Percentage of population undergoing regular eye check-ups |
9 Japan Ophthalmic Drugs Devices Market - Opportunity Assessment |
9.1 Japan Ophthalmic Drugs Devices Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Japan Ophthalmic Drugs Devices Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Japan Ophthalmic Drugs Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.4 Japan Ophthalmic Drugs Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Japan Ophthalmic Drugs Devices Market Opportunity Assessment, By Formulation, 2021 & 2031F |
10 Japan Ophthalmic Drugs Devices Market - Competitive Landscape |
10.1 Japan Ophthalmic Drugs Devices Market Revenue Share, By Companies, 2024 |
10.2 Japan Ophthalmic Drugs Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here